Adjuvant trial for stage II receptor-positive breast cancer: CMF vs. CMF+ tamoxifen in a single centre-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adjuvant trial for stage II receptor-positive breast cancer: CMF vs. CMF+ tamoxifen in a single centre

Published:1988-05 Issue:2 Volume:11 Page:179-186
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Tr

Author:

Mauriac L.,Durand M.,Chauvergne J.,Bonichon F.,Avril A.,Mage P.,Dilhuydy M. H.,Le Treut A.,Wafflart J.,Marée D.,Lagarde C.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF01805842.pdf

Reference25 articles.

1. Bonadonna G, Valagussa P, Rossi A, Tancini G, Brambilla C, Zambetti M, Veronesi U: Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer. Breast Cancer Res Treat 5: 95–115, 1985

2. Clark GM, McGuire WL, Hubay CA, Pearson OH, Marshall JS: Progesterone receptors as a prognostic factor in stage II breast cancer. N Engl J Med 309: 1343–1347, 1983

3. Cox DR: Regression models and life-tables. J R Stat Soc (B) 34: 187–220, 1972

4. Delozier T, Julien JP, Juret P, Veyret C, Couëtte JE, Graic Y, Ollivier JM, de Ranieri E: Adjuvant tamoxifen in postmenopausal breast cancer: preliminary results of a randomized trial. Breast Cancer Res Treat 7: 105–110, 1986

5. Fisher B, and other NSABP investigators: Treatment of primary breast cancer with L-PAM/5-FU and tamoxifen: an interim report. Breast Cancer Res Treat 3 (Suppl 1): 7–17, 1983

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. D2-40 in breast cancer: should we detect more vascular emboli?;Modern Pathology;2008-09-26

2. Efficacy of UFT plus Tamoxifen for Estrogen-Receptor-Positive Breast Cancer and Tamoxifen plus UFT for???Estrogen-Receptor-Negative Breast Cancer;Clinical Drug Investigation;2003

3. Breast ductal carcinoma in situ with microinvasion;Cancer;2002-04-15

4. Adjuvante systemische Therapie;Management des MAMMAKARZINOMS;2002

5. Tamoxifen in high-risk premenopausal women with primary breast cancer receiving adjuvant chemotherapy. Report from the Danish Breast Cancer Co-operative Group DBCG 82B trial;European Journal of Cancer;1999-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3